Diagnostic News and Research

RSS

Salix acquires rights to colon cancer screening agent from Photocure

Salix Pharmaceuticals, Ltd. today announced that the Company has acquired rights to Lumacan™ from Photocure, a Norwegian specialty pharmaceutical company. Lumacan is a novel agent designed to assist in the detection of precancerous and cancerous lesions in the colon.

20 Oct 2010

MabCure announces agreement with Europe's medical centers to explore diagnostic test for ovarian cancer

Biotechnology company MabCure, Inc. today announced that it has signed a collaboration agreement with Catholic University, K.U. Leuven and University Hospital, UZ Leuven, Belgium, together comprising one of the largest and most reputable medical centers in Europe.

20 Oct 2010

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

20/20 GeneSystems, Inc. announced today at the AdvaMed MedTech Conference in Washington, D.C. that the company has been awarded nearly $3 million in grants from the National Cancer Institute's (NCI) Small Business Innovative Research (SBIR) Program to develop tests to help oncologists predict the effectiveness of targeted cancer therapies.

20 Oct 2010

Sysmex America enters contract agreement with Amerinet

Sysmex, a global leader in medical diagnostic testing equipment and information systems technology, today announced a three-year, dual source hematology contract agreement with Amerinet.

From Sysmex America, Inc. 20 Oct 2010

Spectral commences pivotal Toraymyxin trial for severe sepsis

Spectral Diagnostics Inc., a Phase III company seeking FDA approval for its lead theranostics product for the treatment severe sepsis and septic shock, today announced initiation of its U.S. pivotal trial of Toraymyxin™, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream, for patients with severe sepsis.

20 Oct 2010

TearLab announces publication of CPT code for Osmolarity test

TearLab Corporation announced today that, further to its press release of October 8, 2010, a unique new Current Procedural Terminology code that will apply to the TearLab Osmolarity test has now been published by the American Medical Association. The new code will become effective January 1, 2011.

19 Oct 2010

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

Many of the world's preeminent gastroenterologists will gather for the American College of Gastroenterology's (ACG) 75th Annual Scientific Meeting at the Henry B. Gonzalez Convention Center in San Antonio, Texas starting Monday October 18, 2010, to review the latest scientific advances in gastrointestinal research, treatment of digestive diseases and clinical practice management.

19 Oct 2010

getSTDtested.com introduces new payment options for preventative healthcare

Today getSTDtested.com, a leading online social health clinic, announced that consumers preferring alternative payments to credit cards for diagnostic health tests that they have ordered can now pay with cash in a simple web-to-store transaction using PayNearMe services at select convenience stores nationwide.

19 Oct 2010

Opto Circuits, Cardiac Science enter definitive merger agreement

Cardiac Science Corporation and Opto Circuits today announced they have entered into a definitive merger agreement under which Opto Circuits has agreed to acquire all of the outstanding shares of Cardiac Science common stock for $2.30 USD per share.

19 Oct 2010

BD, Walter and Eliza Hall Institute collaborate to commercialize antibodies

The Walter and Eliza Hall Institute of Medical Research in Melbourne, Australia, has entered a collaboration with New Jersey based medical technology company BD to evaluate and potentially develop for research and diagnostic use some of the institute's reagents.

19 Oct 2010

Study reveals diagnostic strategies eliminate ionizing radiation exposure in IBD patients

At the American College of Gastroenterology's (ACG) 75th Annual Scientific meeting in San Antonio, Texas, several studies of the effectiveness of non-X-ray techniques to evaluate Crohn's disease revealed that diagnostic strategies such as capsule endoscopy (CE) and magnetic resonance enteroscopy (MRE) are useful in managing patients with inflammatory bowel disease (IBD) and avoiding ionizing radiation.

19 Oct 2010

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Researchers from Rice University's Laboratory for Nanophotonics (LANP), the radiology department at Baylor College of Medicine (BCM) and the University of Texas MD Anderson Cancer Center are preparing to test a combined approach for diagnosing and treating pancreatic cancer with a specially engineered nanoparticle.

19 Oct 2010

Retroflexion in right colon increases yield of polyps in proximal colon

Research exploring the progression of colon polyps to colorectal cancer and evaluating techniques to improve polyp detection was among the clinical science presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology in San Antonio today.

18 Oct 2010

Lake Health opens Northeast Ohio's first digital hospital

Lake Health made history last October when it opened TriPoint Medical Center, Northeast Ohio's first digital hospital. Now the health system is the first in the United States to deploy the latest generation of a digital wayfinding system featuring a virtual guide -- or avatar -- that helps patients and visitors navigate to their destinations quickly and easily.

18 Oct 2010

Goodwin enters new Biopharmaceutical Development and Manufacturing Agreement with multinational client

Goodwin Biotechnology, Inc., a full service contract biomanufacturing company, today announced that it has signed a new Biopharmaceutical Development and Manufacturing Agreement with a multinational biopharmaceutical client. According to the agreement, Goodwin will develop the process to manufacture a unique therapeutic monoclonal antibody conjugate for diagnostic imaging purposes.

18 Oct 2010

Sanofi-aventis and Harvard University enter research collaboration

Sanofi-aventis announced today a research collaboration with Harvard University. The goal of the collaboration is to advance knowledge in the area of human health through basic and applied research and to promote scientific exchange between Harvard University and sanofi-aventis. The focus of this collaboration is translational biomedical research in multiple therapeutic areas such as cancer, diabetes and inflammation.

18 Oct 2010

Study distinguishes 4 groups of pathological gamblers

Disorganised and emotionally unstable, poorly adapted, suffering from alcohol problems, impulsive, or with a "globally adapted" personality. These are the features of the four diagnosed types of compulsive gamblers identified by researchers at the University Hospital of Bellvitge (IDIBELL) and the Autonomous University of Barcelona (UAB). According to the scientific team, only one of these four shows signs of a significant pathology.

18 Oct 2010

Neogenix to present NPC-1C antibody data at ASCO Annual Meeting

Neogenix Oncology, Inc. announced today that it will present data from its new serum biomarker ELISA utilizing its NPC-1C antibody for patients with colorectal and pancreatic cancers. Results from the study will be presented at the American Society of Clinical Oncology (ASCO)-NCI-EORTC Annual Meeting on Molecular Makers in Cancer, to be held in Hollywood, Florida from October 18-20, 2010.

18 Oct 2010

Series of pan-endoscopies show unparalleled ability to navigate intestinal tract

Spirus Medical, Inc. a leading developer of diagnostic and therapeutic advancement systems for gastroenterology announces a series of pan-endoscopies in an average time of 60 minutes, using a flexible endoscope with an integral drive to power a single use spiral component. The initial clinical series, which was conducted outside the U.S., showed unparalleled ability to navigate the intestinal tract.

18 Oct 2010

Canon to preview CR-2 Digital Non-Mydriatic Retinal Camera at AAO Annual Meeting

Canon U.S.A., Inc., a leader in digital imaging, will preview the lightest Canon retinal camera to-date, the CR-2 Digital Non-Mydriatic Retinal Camera, at the American Academy of Ophthalmology's (AAO) Annual Meeting (October 16 - 19). In addition to the CR-2 retinal camera, which is awaiting FDA clearance, visitors will be able to explore the Company's current full line of ophthalmic solutions in the Canon booth (booth #: 2208).

15 Oct 2010

Diagnostic News and Research

Salix acquires rights to colon cancer screening agent from Photocure

MabCure announces agreement with Europe's medical centers to explore diagnostic test for ovarian cancer

NCI awards 20/20 GeneSystems $3 million to develop tests for targeted cancer therapies

Sysmex America enters contract agreement with Amerinet

Spectral commences pivotal Toraymyxin trial for severe sepsis

TearLab announces publication of CPT code for Osmolarity test

ACG 75th Scientific Meeting to review advances in gastrointestinal research, treatment of digestive diseases

getSTDtested.com introduces new payment options for preventative healthcare

Opto Circuits, Cardiac Science enter definitive merger agreement

BD, Walter and Eliza Hall Institute collaborate to commercialize antibodies

Study reveals diagnostic strategies eliminate ionizing radiation exposure in IBD patients

Researchers to test nanoparticle-based theranostics for pancreatic cancer treatment

Retroflexion in right colon increases yield of polyps in proximal colon

Lake Health opens Northeast Ohio's first digital hospital

Goodwin enters new Biopharmaceutical Development and Manufacturing Agreement with multinational client

Sanofi-aventis and Harvard University enter research collaboration

Study distinguishes 4 groups of pathological gamblers

Neogenix to present NPC-1C antibody data at ASCO Annual Meeting

Series of pan-endoscopies show unparalleled ability to navigate intestinal tract

Canon to preview CR-2 Digital Non-Mydriatic Retinal Camera at AAO Annual Meeting

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News